Benign Prostatic Hyperplasia
Updated Treatment and Prevention Management
DOI:
https://doi.org/10.53366/jimki.v8i3.230Keywords:
Benign prostatic hyperplasia, management, prevention, treatmentAbstract
Background: Benign prostatic hyperplasia (BPH) is a histologic diagnosis which referred to a proliferation of ephitelial and smooth muscle tissues in the transitional zone of the prostate. BPH affects roughly 18-25% of all male aged 40 years and above and 90% of all male aged beyond 80. BPH is known to be able to significantly decrease quality of life and hence people with BPH need treatments to help them alleviate its effects.
Methods: The research was conducted using literature review from the most actual and respected clinical guidelines, scientific literatures, websites, and textbooks on BPH.
Discussion: There are three main groups of treatment, which are conservative, pharmacological, and surgical treatments. Treatment should be chosen from the least invasive first with the aim of increasing quality of life. Even if it is hard to prevent, several preventive measures could be conducted, such as limiting usage of BPH-inducing drugs, doing healthy lifestyle which involves no smoking, active exercise, body weight control, and balanced diet.
Conclusion: BPH is a very prevalent condition on elderly male population. Even though it is not deadly, a proper treatment management need to be done by virtue of its ability to significantly decrease quality of life.
References
1. McVary K, Roehrborn C. Management of benign prostatic hyperplasia [Internet]. American Urological Associaton. 2014 [cited 2020 Aug 28]. Available from: https://www.auanet.org/benign-prostatic-hyperplasia
2. Egan KB. The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract Symptoms: Prevalence and Incident Rates. Urol Clin North Am. 2016 Aug;43(3):289–97.
3. Scher H, Eastham J. Benign and malignant diseases of the prostate. In: Harrison’s principles of internal medicine. 20th ed. New York: McGraw Hill Education; 2018. p. 623–32.
4. Mochtar C, Umbas R, Soebadi D, Rasyid N, Noegroho B, Poernomo BB, et al. Panduan penatalaksanaan klinis pembesaran prostat jinak (benign prostatyic hyperplasia/BPH). 2nd ed. Jakarta: Ikatan Ahli Urologi Indonesia; 2015. 12–25 p.
5. Stelzner S. Intraoperative management of iris prolapse [Internet]. American academy of ophthalmology. 2019 [cited 2020 Aug 30]. Available from: http://eyewiki.aao.org/Intraoperative_Management_of_Iris_Prolapse
6. Lue T. Male sexual dysfunction. In: Smith & Tanagho’s general urology. 18th ed. New York: McGraw Hill Education; 2013. p. 600, 610.
7. Pattanaik S, Mavuduru R, Panda A, Matthew J, Agarwal M, Hwang E, et al. Phosphodiesterase inhibitors for lower urinary tract symptims consistent with benign prostatic hyperplasia. Urol Clin North Am. 2018 Nov 16;(11).
8. National Cancer Institute. TURP [Internet]. National Cancer Institute. 2011 [cited 2020 Sep 1]. Available from: https://www.cancer.gov/publications/dictionaries/cancer-terms
9. Kristal AR, Arnold KB, Schenk JM, Neuhouser ML, Goodman P, Penson DF, et al. Dietary Patterns, Supplement Use, and the Risk of Symptomatic Benign Prostatic Hyperplasia: Results from the Prostate Cancer Prevention Trial. Am J Epidemiol. 2008 Apr 15;167(8):925–34.
10. Roehrborn C. Benign prostatic hyperplasia: etiology, pathophysiology, epidemiology, and natural history. In: Campbell-Walsh urology. 11th ed. Philadelphia: Elsevier; 2016. p. 2440–4.
2. Egan KB. The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract Symptoms: Prevalence and Incident Rates. Urol Clin North Am. 2016 Aug;43(3):289–97.
3. Scher H, Eastham J. Benign and malignant diseases of the prostate. In: Harrison’s principles of internal medicine. 20th ed. New York: McGraw Hill Education; 2018. p. 623–32.
4. Mochtar C, Umbas R, Soebadi D, Rasyid N, Noegroho B, Poernomo BB, et al. Panduan penatalaksanaan klinis pembesaran prostat jinak (benign prostatyic hyperplasia/BPH). 2nd ed. Jakarta: Ikatan Ahli Urologi Indonesia; 2015. 12–25 p.
5. Stelzner S. Intraoperative management of iris prolapse [Internet]. American academy of ophthalmology. 2019 [cited 2020 Aug 30]. Available from: http://eyewiki.aao.org/Intraoperative_Management_of_Iris_Prolapse
6. Lue T. Male sexual dysfunction. In: Smith & Tanagho’s general urology. 18th ed. New York: McGraw Hill Education; 2013. p. 600, 610.
7. Pattanaik S, Mavuduru R, Panda A, Matthew J, Agarwal M, Hwang E, et al. Phosphodiesterase inhibitors for lower urinary tract symptims consistent with benign prostatic hyperplasia. Urol Clin North Am. 2018 Nov 16;(11).
8. National Cancer Institute. TURP [Internet]. National Cancer Institute. 2011 [cited 2020 Sep 1]. Available from: https://www.cancer.gov/publications/dictionaries/cancer-terms
9. Kristal AR, Arnold KB, Schenk JM, Neuhouser ML, Goodman P, Penson DF, et al. Dietary Patterns, Supplement Use, and the Risk of Symptomatic Benign Prostatic Hyperplasia: Results from the Prostate Cancer Prevention Trial. Am J Epidemiol. 2008 Apr 15;167(8):925–34.
10. Roehrborn C. Benign prostatic hyperplasia: etiology, pathophysiology, epidemiology, and natural history. In: Campbell-Walsh urology. 11th ed. Philadelphia: Elsevier; 2016. p. 2440–4.
Downloads
Published
2021-02-21
Issue
Section
Article Review
How to Cite
Benign Prostatic Hyperplasia: Updated Treatment and Prevention Management. (2021). JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, 8(3), 90-97. https://doi.org/10.53366/jimki.v8i3.230
Similar Articles
- imam hermansyah, Eddy Zulfikar, Aton Prasetya Sibala', William Chandra Papendang, Ahmad Fachry Toaha, Yuyun Widaningsih, THE EFFECT OF RADIOTHERAPY ON LEUKOCYTE, HAEMOGLOBIN AND PLATELET COUNT IN PATIENTS WITH NASOPHARYNGEAL CARCINOMA AT HASANUDDIN UNIVERSITY HOSPITAL 2016-2018 , JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia: Vol. 9 No. 1 (2021): JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia Volume 9.1 Edisi Maret - Juli 2021
- Fatimah Azzahra, Rasmi Zakiah Oktarlina, High Boy Karumulborg Hutasoit, FARMAKOTERAPI GANGGUAN ANSIETAS DAN PENGARUH JENIS KELAMIN TERHADAP EFIKASI ANTIANSIETAS , JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia: Vol. 8 No. 1 (2020): JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia Volume 8.1 Edisi November 2019 - Februari 2020
- Putu Diah Ananda Putri Atmaja, Abiyyu Didar Haq, Visakha Vidyadevi Wiguna, KOMBUCHA: THE UTILIZATION OF GUT-BRAIN AXIS MECHANISM IN THE PREVENTION OF DEPRESSION , JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia: Vol. 9 No. 3 (2022): JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia Volume 9.3 Edisi Desember 2021-April 2022
- Nadine Aurelie, DISSECTING FASXIATOR POTENTIAL AS ALTERNATIVE ANTICOAGULANT BY PREVENTING THROMBOSIS THROUGH INHIBITION OF CONTACT ACTIVATION SYSTEM , JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia: Vol. 9 No. 3 (2022): JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia Volume 9.3 Edisi Desember 2021-April 2022
- Atikah Landani, Rani Himayani, Lacrimal System Disorders in Children , JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia: Vol. 8 No. 2 (2020): JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia Volume 8.2 Edisi Maret - Agustus 2020
- Kelvin Kohar, Grady Krisandi, Stephanie Amabella Prayogo, THE ANALYSIS OF ZINC OXIDE NANOPARTICLES AS A POTENTIAL ALTERNATIVE THERAPY FOR URINARY TRACT INFECTION CAUSED BY UROPATHOGENIC ESCHERICHIA COLI , JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia: Vol. 9 No. 1 (2021): JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia Volume 9.1 Edisi Maret - Juli 2021
- Jessica Audrey, THE EFFECTIVENESS OF CARBON NANOPARTICLES AS LYMPH NODE TRACERS IN COLORECTAL CANCER LYMPHADENECTOMY: A SYSTEMATIC REVIEW , JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia: Vol. 9 No. 2 (2021): JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia Volume 9.2 Edisi Agustus - November 2021
- Ni Made Wini Jayesthiwi Wanami Putri, Rovie Hikari Parastan, I Kadek Wahyu Putra Dyatmika, Cokorda Bagus Jaya Lesmana, Coaching Caregiver: The Telehealth Application Based on Education and Consultation for Schizophrenia Caregiver's , JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia: Vol. 8 No. 3 (2021): JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia Volume 8.3 Edisi September 2020 - Februari 2021
- Ayunda Pratiwi L. Tobing, Ance Roslina, Factors Of AFB Conversion In Patients With Pulmunonary Tuberculosis In Haji Medan General Hospital , JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia: Vol. 8 No. 3 (2021): JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia Volume 8.3 Edisi September 2020 - Februari 2021
- Agnes Trilansia Pratiwi, Pengaruh Ekstrak Rosella (Hibiscus sabdariffa Linn) dalam Menurunkan Kadar Gula Darah untuk Diabetes Melitus , JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia: Vol. 6 No. 2 (2018): JIMKI : Jurnal Ilmiah Mahasiswa Kedokteran Indonesia Volume 6.2 Edisi Oktober - Desember 2018
You may also start an advanced similarity search for this article.